MAY 13, 2020 3:33 PM PDT

Fecal Transplant Helps Fight off Antibiotic Resistance

WRITTEN BY: Annie Lennon

Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has shown that the procedure may be able to help those with treatment-resistant bacterial infections. 

For the study, the researchers transferred fecal matter from healthy individuals to 20 patients infected with multi-drug resistant organisms. They then followed the patients for six months after the transplant and compared their prognosis to their symptoms six months prior. 

In the end, they found that fecal transplants managed to completely clear the resistant bacteria in 41% of the 17 patients who completed the follow-up. Although unable to completely clear the resistant bacteria in all patients, the researchers found that the procedure benefited these patients in other ways.

 "Many of these patients have had recurrent, prolonged courses of heavy-duty antibiotics, end-of-the-line treatments with high toxicity profiles, and repeated hospital stays. They had given up work or had family members forced to give up work to care for them - having a huge impact on quality of life," said Benjamin Mullish, a lead researcher of the study and clinical lecturer in the Division of Digestive Diseases, Imperial College London, England. 

"After this experimental treatment, we saw many in this group being able to go back to work, play with their grandkids and have an overall much better quality of life."

The researchers noted that all of the patients who completed the follow-up saw a reduction in bloodstream infections with resistant bacteria. Eight patients were even able to undergo stem-cell transplants within six months of the procedure without any adverse side effects. 

From their results, the researchers thus suggest that fecal transplants may be able to colonize resistant organisms. They also say that it may have a positive impact on other microbiota-related mechanisms, however to understand how these work, further study is required. 


Sources: EurekAlert, Reuters

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 25, 2020
Cannabis Sciences
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
AUG 25, 2020
FDA Approves Cannabis Drug to Treat Rare Genetic Disease
The US Food and Drug Administration has approved Epidiolex, a cannabidiol (CBD) oral solution, to treat seizures linked ...
SEP 13, 2020
Drug Discovery & Development
Scientists Find Way to Reduce Inflammation from Vaccines
SEP 13, 2020
Scientists Find Way to Reduce Inflammation from Vaccines
Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a ...
SEP 11, 2020
Drug Discovery & Development
Novel Therapeutic for ALS
SEP 11, 2020
Novel Therapeutic for ALS
The TDP-43 protein is a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). A ...
OCT 06, 2020
Cardiology
A New Heart Drug Taken from a Yellow Dye
OCT 06, 2020
A New Heart Drug Taken from a Yellow Dye
Cardiovascular disease is an ever-present issue in the modern world.  One of the most unfortunate cardiovascular ev ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
Loading Comments...